Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Change in Cash (2016 - 2025)

Northwest Biotherapeutics' Change in Cash history spans 16 years, with the latest figure at -$1.5 million for Q4 2025.

  • Quarterly results put Change in Cash at -$1.5 million for Q4 2025, down 98.95% from a year ago — trailing twelve months through Dec 2025 was $865000.0 (up 1665.31% YoY), and the annual figure for FY2025 was $865000.0, up 1665.31%.
  • Change in Cash for Q4 2025 was -$1.5 million at Northwest Biotherapeutics, down from $244000.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $11.3 million in Q4 2021 to a low of -$8.2 million in Q1 2022.
  • The 5-year median for Change in Cash is -$353000.0 (2024), against an average of -$347150.0.
  • The sharpest move saw Change in Cash plummeted 741.58% in 2021, then surged 5789.74% in 2022.
  • Year by year, Change in Cash stood at $11.3 million in 2021, then plummeted by 121.71% to -$2.5 million in 2022, then plummeted by 61.42% to -$4.0 million in 2023, then skyrocketed by 80.76% to -$764000.0 in 2024, then crashed by 98.95% to -$1.5 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$1.5 million, $244000.0, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.